The Musculoskeletal Cost of Organ Repair
The Musculoskeletal Cost of Organ Repair
批准号:
10393304
负责人:
LEONIDAS G. KONIARIS
金额:
$0.96万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-06-01 至 2024-02-29
关键词:
AbdomenAcuteAddressAdrenal Cortex HormonesAdrenergic AgentsAmino AcidsBloodBurn injuryCachexiaCatabolismCell physiologyChemicalsCommunicationDataDiseaseEatingEnergy MetabolismExcisionFatty acid glycerol estersFractureGrowthImpairmentInjuryIntakeInterleukin-6InterventionLiteratureLiverMalignant NeoplasmsMediatingMediator of activation proteinMetabolicMolecularMorbidity - disease rateMuscleMuscular AtrophyMusculoskeletalNatural regenerationNutritionalOperative Surgical ProceduresOrganOxidesPathologicPathway interactionsPatientsPharmacologyPhaseProcessReactionRecoveryReportingRoleSignal TransductionSkeletal MuscleSocietiesStarvationTherapeuticTimeTissuesTraumaTraumatic injuryWorkcosthealingimprovedinjury recoverylong bonemortalitymuscle formnutritionorgan injuryrepairedresponsesevere burnssevere injuryskeletal muscle wastingsurgery outcometissue regenerationtissue repair
中文摘要
项目摘要(R01GM137656)
英文摘要
Project Abstract (R01GM137656)
Surviving critical injury or surgery requires an essential catabolic recovery period that typically
extends from days to weeks. This catabolism, defined as “the breakdown of existing molecules into
smaller units that are either oxidized to release energy or used in other anabolic reactions” (Royal
Chemical Society), is systemic, activates rapid loss of skeletal muscle during the period of organ
repair and regeneration, and resolves with recovery. Cuthbertson originally reported the rapid loss of
muscle in long-bone fracture patients in 1930, first terming it “ebb and flow”. This process has
subsequently been termed “hypermetabolism” or “the adrenergic-corticoid phase”. Work by Rhoads
and others found that this catabolic response, rather than nutritional intake, drives repair and
regeneration of tissues following critical injury (including elective surgery). In contrast to starvation,
the post-injury catabolic response is proportional to the degree of injury, supports ongoing energy
needs, and supplies critical substrates (amino acids, fats) to repair, and regenerate injured organs
and tissues. Serious injuries including major trauma, liver resection, and burns can require catabolic
responses over days to weeks to fully recover. Although optimizing preoperative nutrition improves
surgical outcomes, it does not prevent muscle catabolism. Conversely, an impaired catabolic
response is associated with increased morbidity and mortality. Although current literature has focused
on pathological persistence of the catabolic response and energy expenditure following injury,
particularly after burns, acute catabolism is essential to survive injury. To date, little work has
addressed how the recovery from critical injury induces the release of metabolic substrates
from muscle and other stores to meet the acute requirement for the repair and regeneration of
damaged organs. Our data indicate that injured organs are repaired at the expense of skeletal muscle
mass. Furthermore, we found that tissue repair activates the catabolism of muscle partly through a
liver mechanism. Understanding how we heal following injury, and the role of muscle crosstalk in this
process will open new paradigms for therapies after critical injury. We hypothesize that post-injury
catabolism of muscle is: 1) the critical systemic response needed to supply substrates for the repair of
damaged organs, 2) universal after critical injury, including both controlled (surgery) and traumatic
injury, 3) molecularly similar to muscle wasting of cachexia in cancer and other disorders, including in
activation of atrogenes like MuRF1, 4) mediated by the injured organs through
reciprocal, feed-forward Interleukin-6 (IL-6)/JAK/STAT to YAP/TAZ signaling, and 5) amenable to
pharmacologic interventions. Here we will 1) Define mechanisms of organ crosstalk in liver
growth and muscle wasting; 2) Define mechanisms of organ crosstalk via the IL-6/YAP/TAZ
pathway in serious burn injury and investigate the therapeutic potential of YAP/TAZ
modulation to augment recovery from injury; 3) Interrogate the IL-6/YAP/TAZ pathway in blood
and muscle from patients with major liver resection or critical injury requiring delayed
abdominal closure.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core B – Human Biospecimen and Advanced Sequencing Core
-
批准号:10634587
-
项目类别:
-
资助金额:$31.52万
-
财政年份:2021
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
Core B – Human Biospecimen and Advanced Sequencing Core
-
批准号:10172473
-
项目类别:
-
资助金额:$26.66万
-
财政年份:2021
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
Core B – Human Biospecimen and Advanced Sequencing Core
-
批准号:10441216
-
项目类别:
-
资助金额:$31.64万
-
财政年份:2021
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
The Musculoskeletal Cost of Organ Repair
-
批准号:10349585
-
项目类别:
-
资助金额:$31.19万
-
财政年份:2020
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
The Musculoskeletal Cost of Organ Repair
-
批准号:10875228
-
项目类别:
-
资助金额:$11.25万
-
财政年份:2020
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
The Musculoskeletal Cost of Organ Repair
-
批准号:10171874
-
项目类别:
-
资助金额:$41.42万
-
财政年份:2020
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
The Musculoskeletal Cost of Organ Repair
-
批准号:10569038
-
项目类别:
-
资助金额:$38.45万
-
财政年份:2020
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
EGFR therapies for fatty liver surgery
-
批准号:8830782
-
项目类别:
-
资助金额:$32.74万
-
财政年份:2012
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
EGFR therapies for fatty liver surgery
-
批准号:8697048
-
项目类别:
-
资助金额:$33.93万
-
财政年份:2012
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
EGFR therapies for fatty liver surgery
-
批准号:8345698
-
项目类别:
-
资助金额:$33.71万
-
财政年份:2012
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
EGFR therapies for fatty liver surgery
-
批准号:8535753
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
Increasing Functional Liver Mass in Health and Disease
-
批准号:6820902
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2004
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
Increasing Functional Liver Mass in Health and Disease
-
批准号:6944355
-
项目类别:
-
资助金额:$15.15万
-
财政年份:2004
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
The Role of GDF-15 in Organ Injury
-
批准号:6818985
-
项目类别:
-
资助金额:$12.07万
-
财政年份:2001
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
The Role of GDF-15 in Organ Injury
-
批准号:6941664
-
项目类别:
-
资助金额:$12.04万
-
财政年份:2001
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
The Role of GDF-15 in Organ Injury
-
批准号:6360371
-
项目类别:
-
资助金额:$11.96万
-
财政年份:2001
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
The Role of GDF-15 in Organ Injury
-
批准号:6526212
-
项目类别:
-
资助金额:$12.01万
-
财政年份:2001
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
The Role of GDF-15 in Organ Injury
-
批准号:6800759
-
项目类别:
-
资助金额:$12.12万
-
财政年份:2001
-
负责人:LEONIDAS G. KONIARIS
-
依托单位:
海外基金